TITLE

Factors Affecting Survival in Patients with Anal Melanoma

AUTHOR(S)
Podnos, Yale D.; Ni-Chun Tsai; Smith, David; Ellenhorn, Joshua D. I.
PUB. DATE
October 2006
SOURCE
American Surgeon;Oct2006, Vol. 72 Issue 10, p917
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Anal melanoma is an aggressive tumor with a predilection for early infiltration and distant spread, resulting in poor overall survival. Because anal melanoma is rare, only small case series are reported in the literature, making it difficult to draw conclusions about optimal treatment and outcome. The Surveillance, Epidemiology, and End Results database was used to identify patients with anal melanomas from 1973 to 2001. In addition to demographics, disease extent at presentation, treatment administered, overall survival, and survival by decade of diagnosis were collected. A total of 126 patients with a mean age of 69.2 years was diagnosed with anal melanoma. Sixty-one per cent were female. Median follow-up was 22.5 months. Median survival was 10 months for those with distant disease, 13 months for patients with regional spread, and 34 months for patients with local disease (P = 0.0001). Five-year survival was 32 per cent, 17 per cent, and 0 per cent for patients presenting with local, regional, and distant disease, respectively (P = 0.0001). Neither age at diagnosis, operation performed, nor use of radiation significantly affected survival. Anal melanoma remains an uncommon but lethal disease. Extent of disease correlates with overall survival. Survival is improving, but the use and extent of operation are not associated with improved overall survival.
ACCESSION #
22667475

 

Related Articles

  • OSTEOCARTILAGINOUS DIFFERENTIATION OF MUCOSAL MELANOMA IN THE SINONASAL CAVITY. Takeshita, Hajime; Miwa, Takaki; Furukawa, Mitsuru // Annals of Otology, Rhinology & Laryngology;Dec2002 Part 1 of 2, Vol. 111 Issue 12, p1112 

    We present a very rare case of mucosal melanoma with osteocartilaginous differentiation (MMOD). This is the first report of MMOD originating in the sinonasal cavity. Preoperative diagnosis of this tumor from specimens resected for biopsy alone is very difficult, because it has 2 histopathologic...

  • Tumor Conference #39: Malignant Melanoma of Lips and Hard Palate. Bart, Robert S.; Kope, Alfred W. // Journal of Dermatologic Surgery & Oncology;Dec81, Vol. 7 Issue 12, p966 

    The article focuses on three tumor conferences related to malignant melanoma of lips and hard palate, which took place on February 26, 1981, June 17, 1981 and September 23, 1981 respectively. The case discussed in the conferences posed significant diagnostic, therapeutic and theoretical...

  • Expression of the 90K Tumor-Associated Protein in Benign and Malignant Melanocytic Lesions. Cesinaro, Anna Maria; Natoli, Clara; Grassadonia, Antonino; Tinari, Nicola; Iacobelli, Stefano; Trentini, Gian Paolo // Journal of Investigative Dermatology;Jul2002, Vol. 119 Issue 1, p187 

    Discusses the identification of molecular markers that allow an accurate diagnosis of melanoma. Biologic events involved in the melanocyte transformation to a highly invasive and metastatic tumor; Histopathologic differentiation of melanoma from benign melanocytic lesions.

  • MALIGNANT MELANOMA OF SCROTAL SKIN. Gupta, H. K. Das; Gupta, Rohit // Indian Journal of Dermatology;Mar/Apr2011, Vol. 56 Issue 2, p215 

    Black/bluish discolored skin tumor without cuticular covering de novo from site of origin could be a diagnostic feature of melanomas.

  • Man referred for acute decrease in vision. Nandakumar, Namrata; Duker, Jay S. // Hem/Onc Today;9/25/2010, Vol. 11 Issue 18, p34 

    The article discusses the case of a 59-year-old man who was diagnosed with choroidal melanoma and later on underwent plaque therapy.

  • From the Editors. Halpern, Allan C.; Marghoo, Ashfaq A.; Kopf, Alfred W. // Melanoma Letter;Spring2013, Vol. 31, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including diagnosis of slow-growing melanomas, dermoscopy and melanoma screening strategies.

  • Malignant Skin Tumours. Taylor, Michelle // Podiatry Review;Jan/Feb2014, Vol. 71 Issue 1, p4 

    The article discusses the cause and nature of malignant skin tumours. It mentions that the cause of many tumours in the skin remains unknown, but, many factors are identified for such condition, such as external agents, host's genetic make-up and excessive exposure to ultra violet radiation. It...

  • Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape. Sekulic, Aleksandar; Haluska Jr, Paul; Miller, Arlo J.; De Lamo, Josep Genebriera; Ejadi, Samuel; Pulido, Jose S.; Salomao, Diva R.; Thorland, Erik C.; Vile, Richard G.; Swanson, David L.; Pockaj, Barbara A.; Laman, Susan D.; Pittelkow, Mark R.; Markovic, Svetomir N. // Mayo Clinic Proceedings;Jul2008, Vol. 83 Issue 7, p825 

    Malignant melanoma presents a substantial clinical challenge. Current diagnostic methods are limited In their ability to diagnose early disease and accurately predict Individual risk of disease progression and outcome. The lack of adequate approaches to properly define disease subgroups...

  • Outdoor Exercise, Viagra Use and Melanoma Risk.  // Running & FitNews;Mar/Apr2014, Vol. 32 Issue 2, p13 

    The article reports that a study published in the periodical "JAMA Internal Medicine" reveals that intake of sildenafil for treatment of erectile dysfunction (ED) can lead to melanoma. It states that men who consumed sildenafil reported melanoma, basal cell carcinoma and squamous cell carcinoma....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics